HARTFORD INSURANCE GROUP, INC. (HIG)
Wellington Management to Acquire Hartford Funds from The Hartford
INSULET CORP (PODD)
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor
UPBOUND GROUP, INC. (UPBD)
Upbound Group, Inc. Declares Quarterly Cash Dividend of $0.39 for the Third Quarter of 2026
DESTINATION XL GROUP, INC. (DXLG)
Destination XL Group, Inc. Reports First Quarter Financial Results
FIBROBIOLOGICS, INC. (FBLG)
FibroBiologics Announces First Patients Dosed in Phase 1/2 Clinical Trial Evaluating CYWC628 for the Treatment of Diabetic Foot Ulcers
COCRYSTAL PHARMA, INC. (COCP)
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
UPSTREAM BIO, INC. (UPB)
Upstream Bio to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
OVID THERAPEUTICS INC. (OVID)
Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
TENAYA THERAPEUTICS, INC. (TNYA)
Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms
AXSOME THERAPEUTICS, INC. (AXSM)
Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation